(E)-N-(4-((5-(hydroxymethyl)-3-(4-phenoxyphenyl)-1H-pyrazol-1-yl)methyl)phenyl)but-2-enamide

ID: ALA4517485

PubChem CID: 155541029

Max Phase: Preclinical

Molecular Formula: C27H25N3O3

Molecular Weight: 439.52

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C/C=C/C(=O)Nc1ccc(Cn2nc(-c3ccc(Oc4ccccc4)cc3)cc2CO)cc1

Standard InChI:  InChI=1S/C27H25N3O3/c1-2-6-27(32)28-22-13-9-20(10-14-22)18-30-23(19-31)17-26(29-30)21-11-15-25(16-12-21)33-24-7-4-3-5-8-24/h2-17,31H,18-19H2,1H3,(H,28,32)/b6-2+

Standard InChI Key:  ZABVMZNQBAUCFZ-QHHAFSJGSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   34.3413   -5.5366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0082   -6.0088    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6646   -5.5219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4022   -4.7454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5859   -4.7582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0142   -6.8268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7262   -7.2252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8733   -4.0786    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6880   -4.1543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1591   -3.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8166   -2.7446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9983   -2.6726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5309   -3.3403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2869   -2.0763    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.1008   -2.1495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.4405   -2.8948    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2536   -2.9682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7248   -2.2995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3771   -1.5553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5650   -1.4855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5669   -5.7976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9536   -5.2574    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.7335   -8.0396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4446   -8.4379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1467   -8.0205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1330   -7.2005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4213   -6.8058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8603   -8.4186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.8724   -9.2357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5861   -9.6338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1708   -9.6547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.5981  -10.4509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.3118  -10.8490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  6  7  1  0
  6  2  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4  8  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 21 22  1  0
  7 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27  7  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 30 32  2  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4517485

    ---

Associated Targets(Human)

Rec1 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Maver1 (85 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Z-138 (387 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 439.52Molecular Weight (Monoisotopic): 439.1896AlogP: 5.40#Rotatable Bonds: 8
Polar Surface Area: 76.38Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 1.86CX LogP: 5.19CX LogD: 5.19
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.36Np Likeness Score: -1.02

References

1. Ran F, Liu Y, Zhang D, Liu M, Zhao G..  (2019)  Discovery of novel pyrazole derivatives as potential anticancer agents in MCL.,  29  (9): [PMID:30857748] [10.1016/j.bmcl.2019.03.005]

Source